This transcription factor leads to the inhibition of FHL1, IARS2, ARL6IP5, PSIP1 and PRPS1, some of which have been implicated in processes that are involved in the progression of different conditions leading to diabetes. Here, PRPS1 is linked to diabetes mellitus.